Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,161.2
-5.7 (-0.18%)

 

  • STI Straits Times Index
    3,161.2
    -5.7 (-0.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,493.0
    -1.6 (-0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,235.8
    274.8 (1.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,464.3
    66.9 (1.97%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,781.0
    497.4 (1.82%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,096.5
    26.5 (0.44%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,145.9M
  • Value: 1,099.4M
  • Rise: 166
  • Fall: 177
  • Unch: 418

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.116+0.001
Rex Intl0.235+0.025
Abundance Intl0.046+0.004
Raffles Edu0.080-0.020
Genting Sing0.805-0.005
Mercurius0.057-0.004
KTL Global^0.122+0.004
YZJ Shipbldg SGD1.390+0.020
ISDN0.810+0.045
ThaiBev0.645-0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,672.7 -105.6
HSI 26,235.8 +274.8
HSCEI 9,336.6 +103.4
Jakarta 6,096.5 +26.5
Nikkei 225 27,781.0 +497.4
SSE Comp 3,464.3 +66.9
Shanghai A 3,630.9 +70.2
Shanghai B 257.6 +3.6
KOSPI 3,223.0 +20.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VERICEL CORP VERICEL CORPORATION
Updated on 30 Jul 2021 (End of trading day)
Last (USD): 52.940 Change: -0.830 High: 54.130 Remarks: -
Change (%): -1.54 Low: 52.500
Open 53.470 Yesterday's Close 53.769999999999996
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 199,435 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.06178 Trailing EPS (USD) e 0.09233 NAV (USD) b 3.0246
PE a 856.912 Trailing PE f 573.380 Price / NAV b 17.5031
Dividend (USD) d - Cash In Hand (USD) g 1.2545 Issued & Paid-up Shares c 46,355,600
Dividend Yield (%) d - Price / Cash In Hand g 42.200 Treasury Shares h -
Market Cap (M) 2,454.065 Enterprise Value (M) 2,422.973
Piotroski F Score 4 Exchange Code VCEL Par Value ( $ ) n.a.
52 Weeks Volatility (%) 65.07 Free Float (%) 98.8
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Mar 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VERICEL CORP NASDAQ 2,454.065 856.912 573.380 17.5031 -
Industry Medical Specialties NASDAQ 3,531.356 173.475 129.856 10.8193 0.024
Local Peer INTUITIVE SURGICAL INC NASDAQ 117,733.892 111.007 72.559 10.8636 -
Local Peer IDEXX LABORATORIES INC NASDAQ 57,865.513 99.463 85.828 82.3479 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 55,063.246 31.006 78.836 16.2697 -
Local Peer DEXCOM INC NASDAQ 49,875.025 101.043 106.639 - -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 29,590.316 40.668 34.707 9.3180 -
Local Peer INSULET CORPORATION NASDAQ 19,162.429 2,818.035 2,153.082 32.7395 -
Local Peer HOLOGIC INC NASDAQ 19,021.664 17.057 9.335 4.9061 -
Local Peer NOVOCURE LTD NASDAQ 15,962.828 805.871 1,584.714 - -
Local Peer MASIMO CORPORATION NASDAQ 14,996.949 62.409 67.043 10.7796 -
Local Peer ABIOMED INC NASDAQ 14,834.163 65.776 65.776 11.1562 -
Local Peer DENTSPLY SIRONA INC NASDAQ 14,417.721 - 82.908 2.9263 0.607
Local Peer BRUKER CORPORATION NASDAQ 12,462.602 78.977 61.091 12.8785 0.195
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), QUIDEL CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), INMODE LTD (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), NUVASIVE INC (NASDAQ), AXONICS INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), HESKA CORP (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), EARGO INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ATRION CORP (NASDAQ), VIEWRAY INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SI BONE INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), BIOVENTUS INC (NASDAQ), CERUS CORP (NASDAQ), 908 DEVICES INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), AXOGEN INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PAVMED INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), NEUROPACE INC (NASDAQ), ZYNEX INC (NASDAQ), SIENTRA INC (NASDAQ), SOLITON INC (NASDAQ), ONCOCYTE CORP (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), LUCIRA HEALTH INC (NASDAQ), CVRX INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), NEURONETICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), CORMEDIX INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), INTRICOM CORP (NASDAQ), TELA BIO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), IRIDEX CORP (NASDAQ), CELSION CORPORATION (NASDAQ), AVINGER INC (NASDAQ), LENSAR INC (NASDAQ), BIOLASE INC (NASDAQ), NEUROMETRIX INC (NASDAQ), NEPHROS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 214,959.684 48.057 33.847 - 1.261
Global Peer DANAHER CORP NYSE 212,378.111 60.507 60.507 5.3783 0.241
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 212,239.050 33.292 24.690 5.7589 0.164
Global Peer MEDTRONIC PLC NYSE 176,467.509 48.937 48.937 3.4314 1.769
Global Peer STRYKER CORP NYSE 102,170.390 63.896 49.050 7.3929 0.867
Global Peer BECTON DICKINSON & CO NYSE 74,376.959 96.971 45.352 2.9962 1.232
Global Peer EDWARDS LIFESCIENCES CORP NYSE 69,791.186 84.760 71.735 - -
Global Peer BOSTON SCIENTIFIC CORP NYSE 64,793.496 - 138.448 - -
Global Peer AGILENT TECHNOLOGIES INC NYSE 46,496.571 64.668 50.267 9.6667 0.474
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,237.050 31.214 31.529 2.9799 2.214
Other Global Peers RESMED INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), MICROPORT-1000 (HKEx), MICROPORT-100 (HKEx), FISHER & PAYKEL HEALTHCARE CORP (ASX), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), ANGELALIGN (HKEx), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), Top Glove (SGX), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), CARDIOFLOW-B (HKEx), EBOS GROUP (ASX), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), PEIJIA-B (HKEx), LIFETECH SCI (HKEx), GLAUKOS CORPORATION (NYSE), SUPERMX (Bursa), ZYLOXTB-B (HKEx), KANGJI MEDICAL (HKEx), AVANOS MEDICAL INC (NYSE), BUTTERFLY NETWORK INC (NYSE), AK MEDICAL (HKEx), NANOSONICS LIMITED (ASX), CIRC (HKEx), CRYOLIFE INC (NYSE), CHUNLI MEDICAL (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), MODERN DENTAL (HKEx), KDL MEDICAL (HKEx), STEREOTAXIS INC (NYSE American), VAPOTHERM INC (NYSE), BASECARE-B (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTH (HKEx), Medtecs Intl (SGX), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), UGHealthcare (SGX), INVACARE CORP (NYSE), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHA PRO TECH (NYSE American), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), MICRO-X LTD (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), OPTISCAN IMAGING (ASX), KELFRED (HKEx), VOLITIONRX LIMITED (NYSE American), CLEANSPACE HOLDINGS LTD (ASX), SDI LTD (ASX), MILESTONE SCIENTIFIC INC (NYSE American), ADVENTA (Bursa), YUNNAN ENERGY (HKEx), RESONANCE HEALTH LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), RGTBHD (Bursa), Biolidics (SGX), COMPUMEDICS (ASX), CARDIEX LTD (ASX), LKL (Bursa), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), Yunnan Energy (SGX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), METALICITY LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE American), LIFE HEALTHCARE (HKEx), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.300
+2.52 %
10 Days -+3.030
+6.07 %
20 Days -+1.170
+2.26 %
Medium Term Return 3 Months --9.120
-14.70 %
6 Months -+8.570
+19.31 %
1 Year -+35.750
+207.97 %
Long Term Return 2 Years -+35.250
+199.27 %
3 Years -+42.740
+419.02 %
5 Years -+50.660
+2221.93 %
Annualised Return Annualised --
+87.57 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 14.450 - 68.940 Change From 1 Year Low +38.490 % Change From 1 Year Low (%) +266.37
Change From 1 Year High -16.000 % Change From 1 Year High (%) -23.21
2 Years Range 6.780 - 68.940 Change From 2 Years Low +46.160 % Change From 2 Years Low (%) +680.83
Change From 2 Years High -16.000 % Change From 2 Years High (%) -23.21
5 Years Range 2.000 - 68.940 Change From 5 Years Low +50.940 % Change From 5 Years Low (%) +2547.00
Change From 5 Years High -16.000 % Change From 5 Years High (%) -23.21
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
30 Jul 2021 53.470 54.130 52.500 52.940 199,435 -
29 Jul 2021 54.650 55.050 53.500 53.770 180,511 -
28 Jul 2021 53.760 54.390 52.370 54.160 280,524 -
27 Jul 2021 51.650 53.940 50.500 53.310 284,256 -
26 Jul 2021 53.180 53.180 51.250 51.640 225,555 -
23 Jul 2021 53.090 53.840 52.270 53.240 212,006 -
22 Jul 2021 54.440 54.770 52.400 52.840 222,133 -
21 Jul 2021 51.990 55.110 51.350 54.390 306,156 -
20 Jul 2021 50.260 52.740 50.090 52.350 310,081 -
19 Jul 2021 49.960 52.150 49.148 49.910 416,910 -
16 Jul 2021 52.810 53.110 50.645 50.690 240,643 -
15 Jul 2021 51.500 52.660 50.500 52.150 451,108 -
14 Jul 2021 54.260 54.260 51.811 52.030 325,451 -
13 Jul 2021 53.840 54.870 52.110 53.570 337,951 -
12 Jul 2021 53.700 54.400 52.140 53.930 313,403 -
09 Jul 2021 55.170 55.170 52.650 53.060 320,467 -
08 Jul 2021 53.900 55.170 53.060 54.580 367,866 -
07 Jul 2021 54.100 55.820 53.740 55.500 758,276 -
06 Jul 2021 51.770 54.250 50.760 53.950 450,434 -
02 Jul 2021 52.810 52.810 51.450 51.770 248,420 -
01 Jul 2021 52.550 53.600 51.690 52.630 538,951 -
30 Jun 2021 57.190 57.360 51.430 52.500 1,747,814 -
Summary
Current 2 Weeks
(19 Jul 2021 to 30 Jul 2021)
49.960 55.110 49.148 52.940 2,637,567 -
Previous 2 Weeks
(02 Jul 2021 to 16 Jul 2021)
52.810 55.110 49.148 50.690 3,814,019 -
4 Weeks from
(04 Jun 2021 to 01 Jul 2021)
55.450 55.850 49.148 52.630 11,511,759 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.